BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16340793)

  • 21. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
    Benda B; Ljunggren HG; Peach R; Sandberg JO; Korsgren O
    Cell Transplant; 2002; 11(7):715-20. PubMed ID: 12518898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host systemic and local nitric oxide levels do not correlate with rejection of pig proislet xenografts in mice.
    Simeonovic CJ; Cordery DV; Van Leeuwen B; Popp SK; Townsend MJ; Paule MF; Wilson JD; Cowden WB
    Xenotransplantation; 2002 May; 9(3):169-82. PubMed ID: 11983015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
    Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
    Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
    Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
    Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid destruction of encapsulated islet xenografts by NOD mice is CD4-dependent and facilitated by B-cells: innate immunity and autoimmunity do not play significant roles.
    Xu BY; Yang H; Serreze DV; MacIntosh R; Yu W; Wright JR
    Transplantation; 2005 Aug; 80(3):402-9. PubMed ID: 16082337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet allo- and xenotransplantation in normal, intercellular adhesion molecule-1-deficient, and P selectin-deficient mice.
    Sandberg JO; Korsgren O
    Transplantation; 1997 Aug; 64(4):584-9. PubMed ID: 9293869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T cells are capable of rejecting pancreatic islet xenografts.
    Yi S; Feng X; Hawthorne W; Patel A; Walters S; O'Connell PJ
    Transplantation; 2000 Sep; 70(6):896-906. PubMed ID: 11014643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophages.
    Schmidt P; Krook H; Maeda A; Korsgren O; Benda B
    Diabetes; 2003 May; 52(5):1111-8. PubMed ID: 12716740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.
    Schröppel B; Zhang N; Chen P; Zang W; Chen D; Hudkins KL; Kuziel WA; Sung R; Bromberg JS; Murphy B
    J Am Soc Nephrol; 2004 Jul; 15(7):1853-61. PubMed ID: 15213273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of anti-donor antibody in the rejection of pig proislet xenografts in mice.
    Simeonovic CJ; McKenzie KU; Wilson JD; Zarb JC; Hodgkin PD
    Xenotransplantation; 1998 Feb; 5(1):18-28. PubMed ID: 9507729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
    Gordon EJ; Kelkar V
    Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo-expanded baboon CD39 +  regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ
    Huang D; Wang Y; Hawthorne WJ; Hu M; Hawkes J; Burns H; Davies S; Gao F; Chew YV; Yi S; O'Connell PJ
    Xenotransplantation; 2017 Nov; 24(6):. PubMed ID: 28963731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate and adaptive immune responses to nonvascular xenografts: evidence that macrophages are direct effectors of xenograft rejection.
    Fox A; Mountford J; Braakhuis A; Harrison LC
    J Immunol; 2001 Feb; 166(3):2133-40. PubMed ID: 11160265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs.
    Safley SA; Kapp JA; Weber CJ
    Cell Transplant; 2002; 11(7):695-705. PubMed ID: 12518896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple clinically relevant immunotherapies prolong the function of microencapsulated porcine islet xenografts in diabetic NOD mice without the use of anti-CD154 mAb.
    Safley SA; Barber GF; Holdcraft RW; Gazda LS; Duncanson S; Poznansky MC; Sambanis A; Weber CJ
    Xenotransplantation; 2020 Jul; 27(4):e12577. PubMed ID: 31903659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
    Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli AM; Adorini L
    J Immunol; 2001 Aug; 167(4):1945-53. PubMed ID: 11489974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.